🇫🇷
France · FR · FR:63380548
DOCETAXEL KABI 160 mg/8 ml, solution à diluer pour perfusion
ATC L01CD02
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerFRESENIUS KABI DEUTSCHLAND (ALLEMAGNE)
CountryFR (France)
ATC codeL01CD02
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009223592501 flacon(s) en verre de 8 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "63380548",
"date_amm": "2012-05-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/770",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L01CD02.
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- NLDemotaxel Mono 20 mg/ml, concentraat voor oplossing voor infusieDemo S.A. Pharmaceutical Industry
Access this data programmatically
Query DOCETAXEL KABI 160 mg/8 ml, solution à diluer pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.